OncoEthix presents Phase I interim results for novel anticancer compound OTX015 at AACR 2014
8 April 2014 | By OncoEthix
OncoEthix announced that the interim results from its ongoing Phase I clinical trial of OTX015, in patients with hematologic malignancies, were presented at the annual American Association of Cancer Research...